XML 61 R50.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Accrued Expenses and Other Liabilities (Details) - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Accrued Expenses and Other Liabilities    
Accrued marketing expenses $ 1,021,563 $ 1,013,497
Other expenses 310,603 313,254
Accrued preclinical and clinical trial expenses 364,460 405,792
Compensation and related benefits 543,574 332,641
Accrued manufacturing expenses 18,915 97,877
Advance payments received from customers for manufacturing materials 476,288  
Accrued franchise tax   38,800
Accrued expenses and other current liabilities $ 2,735,403 $ 2,201,861